Bullous pemphigoid: end of the century overview, J Dermatol, vol.28, pp.647-50, 2001. ,
Bullous pemphigoid: a review of its diagnosis, associations and treatment, Am J Clin Dermatol, vol.18, pp.513-541, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01825913
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180, J Clin Invest, vol.92, pp.2480-2488, 1993. ,
Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice, J Immunol, vol.187, pp.1176-83, 2011. ,
but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation, J Immunol, vol.169, pp.3987-92, 2002. ,
Comparison of CD163 + CD206 + M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid, Dermatology (Basel), vol.229, pp.369-78, 2014. ,
92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen, J Clin Invest, vol.93, pp.2022-2052, 1994. ,
Exploring the full spectrum of macrophage activation, Nat Rev Immunol, vol.8, pp.958-69, 2008. ,
The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, vol.25, pp.677-86, 2004. ,
Alternative activation of macrophages: an immunologic functional perspective, Annu Rev Immunol, vol.27, pp.451-83, 2009. ,
Alternative activation of macrophages, Nat Rev Immunol, vol.3, pp.23-35, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00474829
Macrophage polarization in health and disease, Sci World J, vol.11, pp.2391-402, 2011. ,
Macrophage polarization in inflammatory diseases, Int J Biol Sci, vol.10, pp.520-529, 2014. ,
Macrophage heterogeneity in the context of rheumatoid arthritis, Nat Rev Rheumatol, vol.12, pp.472-85, 2016. ,
Biochemical and functional characterization of three activated macrophage populations, J Leukoc Biol, vol.80, pp.1298-307, 2006. ,
Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors, J Immunol, vol.166, pp.6861-6869, 2001. ,
Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid, J Invest Dermatol, vol.134, pp.2908-2925, 2014. ,
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Sci Rep, vol.5, p.18001, 2015. ,
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, J Allergy Clin Immunol, vol.139, pp.863-72, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01754072
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group, Arch Dermatol, vol.134, pp.1075-80, 1998. ,
Tumorassociated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction, J Invest Dermatol, vol.129, pp.1016-1041, 2009. ,
Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation, Biol Chem, vol.378, pp.265-71, 1997. ,
Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid, Oncotarget, vol.9, pp.35517-35544, 2018. ,
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity, Am J Pathol, vol.111, pp.331-371, 1983. ,
1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro, Exp Hematol, vol.28, pp.575-83, 2000. ,
Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization?, Front Pharmacol, vol.9, p.71, 2018. ,
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro, Mol Immunol, vol.88, pp.58-68, 2017. ,
Molecular mechanisms that influence the macrophage m1-m2 polarization balance, Front Immunol, vol.5, p.614, 2014. ,
Update on the role of alternatively activated macrophages in asthma, J Asthma Allergy, vol.9, pp.101-108, 2016. ,
Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10, Exp Dermatol, vol.7, pp.157-61, 1998. ,
Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, Br J Dermatol, vol.138, pp.611-615, 1998. ,
Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid, Arch Dermatol Res, vol.288, pp.353-360, 1996. ,
IL-10 enhances IgE-mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-deficient mice, J Immunol, vol.196, pp.4865-76, 2016. ,
Immunoglobulin E and bullous pemphigoid, Eur J Dermatol, vol.28, pp.440-448, 2018. ,
Alternatively activated (M2) macrophage phenotype is inducible by Endothelin-1 in cultured human macrophages, PLoS ONE, vol.11, 2016. ,
Macrophage plasticity and polarization in tissue repair and remodelling, J Pathol, vol.229, pp.176-85, 2013. ,
Macrophage polarization and plasticity in health and disease, Immunol Res, vol.53, pp.11-24, 2012. ,
Bullous pemphigoid associated with adalimumab therapy in a patient with ulcerative colitis, Case Rep Dermatol, vol.10, pp.145-153, 2018. ,
Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis. JAAD Case Rep, vol.3, pp.339-380, 2017. ,
Etanerceptinduced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient, JAAD Case Rep, vol.2, pp.25-32, 2016. ,
Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports, Dermatology (Basel), vol.221, pp.201-206, 2010. ,
Bullous pemphigoid during long-term TNF-alpha blocker therapy, Dermatology (Basel), vol.219, pp.357-365, 2009. ,